Salivary Expression of SOX7 in Oral Squamous Cell Carcinoma: Diagnostic Accuracy Study

Recruiting

• Conditions: Oral Cancer; Oral Squamous Cell Carcinoma
• Interventions: Diagnostic Test: ELISA

• Registration Number: NCT06031337
• Lead Sponsor: Fayoum University

Brief Summary

The study will include patients with oral cancer and healthy controls of both sexes. Subjects having any systemic diseases or other types of cancer will be excluded. All subjects will be selected from Oral Medicine Department, Faculty of Dentistry, Al Ahram Canadian University and Fayoum University. Informed consent will be obtained from all subjects enrolled in this study after explanation of the whole procedure.

Detailed Description

Not available

Study Timeline

• Status Verified: 2023-09
• Study First Submitted: 2023-09-02
• Study Start: 2023-09-03
• Study First Submitted QC: 2023-09-08
• Study First Posted: 2023-09-11
• Last Update Submitted: 2023-09-17
• Last Update Posted: 2023-09-21
• Primary Completion: 2023-11-22
• Study Completion: 2023-12-01

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 46

Inclusion Criteria

• patients with oral cancer

Exclusion Criteria

• any systemic diseases or other types of cancer will be excluded

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Arm && Interventions

Group	Intervention	Description
Control Group	ELISA	23 age-and-sex-matched healthy individuals, as normal controls
Oral Cancer Group	ELISA	23 patients with oral cancer

Primary Outcome Measures

Name	Time	Method
salivary expression of SOX7	2 months

Trial Locations

Locations (1)

Fayoum University; 🇪🇬 Fayoum, Egypt